Vanda Pharmaceuticals Inc. (VNDA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 4,114,125 $23,244,806 -4% 0.03%
2. 2,153,307 $12,166,185 +23% 1.23%
3.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,593,516 $9,003,365 +58% 0.52%
4.
D E Shaw

D. E. Shaw

692,736 $3,913,959 -62% 0%
5.
Two Sigma Advisors

John Overdeck And David Siegel

214,100 $1,209,665 -70% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.97 3,239 Large Shareholder, Other 1,103,617 2015-12-16 Filing
$8.97 4,441 Large Shareholder, Other 2,740,122 2015-12-16 Filing
$8.97 3,490 Large Shareholder, Other 2,152,952 2015-12-16 Filing
$8.61 93,634 Large Shareholder, Other 1,100,378 2015-12-11 Filing
$8.61 128,374 Large Shareholder, Other 2,735,681 2015-12-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.92 2,251 228,763 2024-07-29 Filing
$4.18 8,941 196,825 2024-03-05 Filing
$4.41 8,147 205,766 2024-03-04 Filing
$4.21 9,229 129,789 2024-03-05 Filing
$4.41 7,498 139,018 2024-03-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 8,346,367 $35,221,670 0%
2. 3,456,087 $14,584,687 0%
3. 2,022,968 $8,536,923 0%
4. 1,967,985 $8,305,054 0%
5. 1,919,002 $8,098,188 0%
News See All